chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Full blood count normal, Joint swelling, Macule, Metabolic function test, Musculoskeletal chest pain
Clinical narrative: Pt presented to emergency dept 3 days after vaccination with acute chest wall pain, acute coronary syndrome ruled out, pericarditis/myocarditis ruled out.  He had a very tender, nonerythematous firm chest wall mass at the right costochondral junction that has been present from 1/3 to date (1/14/22). Ultrasound showed no pericarditis in ED; chest xray was unremarkable. He simultaneously had a rash on his upper shoulders that when I saw him on 1/10  looked like pityriasis (pink-tan macules, ovoid, no scale, nontender, not itchy.   At one point this looked like another clinician like urticaria, but the flat macules that were present on my exam were not itchy and were persistent over days.   He has had no fever or chills, but has had, since the vaccine, episodic and relatively quickly resolving (over 1-2 days) swelling of the elbow, and the nasal bridge.  He does have a single palpable cervical lymph node.   -originally entertained possibility of Tietze's syndrome after case of pityriasis but with extremity joint involvement and nasal bridge swelling find this now less likely -ddx does include relapsing polychondritis but no vestibular/acoustic/otic or ophthalmic involvement; also quite rare.  Appreciate the work of our public health colleagues.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pityriasis, Polychondritis, Rash, Red blood cell sedimentation rate normal
Clinical narrative: Pt presented to emergency dept 3 days after vaccination with acute chest wall pain, acute coronary syndrome ruled out, pericarditis/myocarditis ruled out.  He had a very tender, nonerythematous firm chest wall mass at the right costochondral junction that has been present from 1/3 to date (1/14/22). Ultrasound showed no pericarditis in ED; chest xray was unremarkable. He simultaneously had a rash on his upper shoulders that when I saw him on 1/10  looked like pityriasis (pink-tan macules, ovoid, no scale, nontender, not itchy.   At one point this looked like another clinician like urticaria, but the flat macules that were present on my exam were not itchy and were persistent over days.   He has had no fever or chills, but has had, since the vaccine, episodic and relatively quickly resolving (over 1-2 days) swelling of the elbow, and the nasal bridge.  He does have a single palpable cervical lymph node.   -originally entertained possibility of Tietze's syndrome after case of pityriasis but with extremity joint involvement and nasal bridge swelling find this now less likely -ddx does include relapsing polychondritis but no vestibular/acoustic/otic or ophthalmic involvement; also quite rare.  Appreciate the work of our public health colleagues.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Rheumatoid factor, Swelling face, Troponin normal
Clinical narrative: Pt presented to emergency dept 3 days after vaccination with acute chest wall pain, acute coronary syndrome ruled out, pericarditis/myocarditis ruled out.  He had a very tender, nonerythematous firm chest wall mass at the right costochondral junction that has been present from 1/3 to date (1/14/22). Ultrasound showed no pericarditis in ED; chest xray was unremarkable. He simultaneously had a rash on his upper shoulders that when I saw him on 1/10  looked like pityriasis (pink-tan macules, ovoid, no scale, nontender, not itchy.   At one point this looked like another clinician like urticaria, but the flat macules that were present on my exam were not itchy and were persistent over days.   He has had no fever or chills, but has had, since the vaccine, episodic and relatively quickly resolving (over 1-2 days) swelling of the elbow, and the nasal bridge.  He does have a single palpable cervical lymph node.   -originally entertained possibility of Tietze's syndrome after case of pityriasis but with extremity joint involvement and nasal bridge swelling find this now less likely -ddx does include relapsing polychondritis but no vestibular/acoustic/otic or ophthalmic involvement; also quite rare.  Appreciate the work of our public health colleagues.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Blood luteinising hormone decreased, Blood oestrogen decreased, Blood test normal, Heavy menstrual bleeding, Hypertension
Clinical narrative: I had another unexpected period, a lot of cramping, and infertility. I had an extreme amount of bleeding for 15 days of my cycle, which has never happened before. I had high blood pressure and a fever up to 15 days after the vaccination. (Please note, my husband and I have been practicing Marquette method of Natural Family Planning (NFP) since 2/21/2020. At the time of my second dose of the COVID-19 injection, I have charted 23 cycles. During this cycle, it began on 10/22/21, I did not have a rise in estrogen nor LH. This is entirely abnormal prior to the injections and has never happened before in my life. Then, I only had a 24 day cycle, which my average is between 30 to 32 days exactly.)
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Infertility, Menstruation irregular, Muscle spasms, Polymenorrhoea, Pyrexia
Clinical narrative: I had another unexpected period, a lot of cramping, and infertility. I had an extreme amount of bleeding for 15 days of my cycle, which has never happened before. I had high blood pressure and a fever up to 15 days after the vaccination. (Please note, my husband and I have been practicing Marquette method of Natural Family Planning (NFP) since 2/21/2020. At the time of my second dose of the COVID-19 injection, I have charted 23 cycles. During this cycle, it began on 10/22/21, I did not have a rise in estrogen nor LH. This is entirely abnormal prior to the injections and has never happened before in my life. Then, I only had a 24 day cycle, which my average is between 30 to 32 days exactly.)
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Complaint about headaches on 1/11 Then
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Pfizer lot #FJ6369 with temp excursion. Reported to Pfizer company and ok?d for use. Instructed by their staff to report each dose given in this system.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Pfizer lot #FJ6369 with temp excursion. Reported to Pfizer company and ok?d for use. Instructed by their staff to report each dose given in this system.?
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Computerised tomogram thorax, SARS-CoV-2 test positive
Clinical narrative: Patient stated that he received both shots in the 2 shot Moderna series in 2021 - unable to provide exact dates nor location vaccine was administered.   Hospital stay extended due to contraction of Covid illness.
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Atrioventricular block complete, COVID-19, COVID-19 pneumonia, SARS-CoV-2 test positive
Clinical narrative: Received Moderna vaccines on 2/4, 3/5/21 COVID-19 positive by PCR on  1/3/22 admitted to hospital 1/10-1/14/22 for complete AV Block, COVID-19 pneumonia.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Pfizer lot #FJ6369 with temp excursion. Reported to Pfizer company and ok?d for use. Instructed by their staff to report each dose given in this system.
Age: 6.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Ocular hyperaemia, Oropharyngeal pain, Pain, Pyrexia
Clinical narrative: Lethargy, sore throat, blood shot eyes, body aches,fever
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Pfizer lot #FJ6369 with temp excursion. Reported to Pfizer company and ok'd for use. Instructed by their staff to report each dose given in this system.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Diarrhoea, Encephalopathy, Hypophagia
Clinical narrative: Pt diagnosed with COVID-19 infection on 1/8 in ER.  Returned due to diarrhea, weakness, altered mental status, and poor PO intake.  Admitted due to acute encephalopathy.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mental status changes
Clinical narrative: Pt diagnosed with COVID-19 infection on 1/8 in ER.  Returned due to diarrhea, weakness, altered mental status, and poor PO intake.  Admitted due to acute encephalopathy.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Joint range of motion decreased, Magnetic resonance imaging abnormal, X-ray limb abnormal
Clinical narrative: Adverse Event: Right shoulder pain, decreased range of motion  Chiropractic 3 visits (first visit end of October 2021), 11/5/2021; 11/10/2021 - referred to Physical Therapy Physical Therapy twice weekly starting  11/22/2021 (still attending twice weekly) Steroid injection R shoulder joint 11/30/2021 (Orthopedics) Steroid injection R shoulder bursa  1/11/2022 (Orthopedics)
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was beyond use date
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Pfizer lot #FJ6369 with temp excursion. Reported to Pfizer company and ok'd for use. Instructed by their staff to report each dose given in this system.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Neuralgia, Paralysis
Clinical narrative: NERVE PAIN, STIFFNESS,  PATIENT FELT PARALYZED  COULDN'T MOVE
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Patient felt dizzy after receiving vaccine, vitals signs checked and stable, BP 134/84, HR 80, RR 18, Temp 98.0, SPo2 98%. He drank water and was monitored for 30minutes. No acute ditress noted.  He stated he was ok after 30minutes observation and ready to leave.  Accompained  by Mom.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Pfizer lot #FJ6369 with temp excursion. Reported to Pfizer company and ok?d for use. Instructed by their staff to report each dose given in this system.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anticoagulant therapy, Atrial flutter, Blood glucose normal, Blood thyroid stimulating hormone normal
Clinical narrative: 52 y.o. female with history as outlined below as well as pertinent history of morbid obesity and type 2 diabetes mellitus who was referred to the ER from her clinic for evaluation of new onset atrial flutter.   Acute respiratory failure with hypoxia, resolved Pneumonia due to COVID-19, improved Likely bacterial pneumonia Fever, resolved Pt with positive test for SARS-CoV-2 6 days PTA; she is vaccinated (received 2 doses of Moderna; has not received booster). Chest x-ray with findings suggestive of superimposed bacterial pneumonia (possibly improving, as patient has been on Augmentin since 12/30). Completed course while inpt w/ cefdinir, azithromycin. Placed on decadron given O2 requirements. Weaned off O2 on 1/10, stopped decadron. D-dimer was elevated 1.33 -however patient is already on Eliquis. No DVT noted on u/s. -- s/p decadron course -- s/p CAP treatment -- remains on eliquis as below     Atrial flutter with RVR, new Heart rate up to 160s on presentation, likely due to above. CHA2DS2-VASc score of 3. Over course of her admission, metoprolol added and dose increased. Diltiazem added. Continue as needed IV metoprolol. Cardiology consulted, appreciate recommendations. Started on Eliquis 5 mg twice daily. Normal TSH -- cont metoprolol, diltiazem, eliquis -- Continue telemetry monitor -- F/U up with cardiology as an outpatient   Hx of Hypertension continue lisinopril, metoprolol    Type 2 diabetes with hyperglycemia  Hx of type 2 diabetes mellitus on Metformin and glipizide PTA.  Lantus increased doses this admission and now up to 50 units twice daily while on steroids BG today a.m. was 107.  Lantus lowered from 40 BID to 40 units qhs,  She is off steroids, so requiring less insulin cont scheduled mealtime insulin as per carb count increased to 4 units per carb choice.  A1c 10.1 on January 3. Cont home oral DM regimen w/ glipizide, metformin. Cont to wean down insulin as able.    History of schizophrenia, schizoaffective disorder bipolar type, history of psychosis Resume home medications Received monthly paliperidone injection on 1/12.   Hx of OSA, obesity    VTE PPX: Eliquis Code- Full   Dispo:  No further inpatient work-up anticipated.  Awaiting group home to take the patient back
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: CHA2DS2-VASc-score, COVID-19, COVID-19 pneumonia, Cardiac telemetry, Chest X-ray abnormal
Clinical narrative: 52 y.o. female with history as outlined below as well as pertinent history of morbid obesity and type 2 diabetes mellitus who was referred to the ER from her clinic for evaluation of new onset atrial flutter.   Acute respiratory failure with hypoxia, resolved Pneumonia due to COVID-19, improved Likely bacterial pneumonia Fever, resolved Pt with positive test for SARS-CoV-2 6 days PTA; she is vaccinated (received 2 doses of Moderna; has not received booster). Chest x-ray with findings suggestive of superimposed bacterial pneumonia (possibly improving, as patient has been on Augmentin since 12/30). Completed course while inpt w/ cefdinir, azithromycin. Placed on decadron given O2 requirements. Weaned off O2 on 1/10, stopped decadron. D-dimer was elevated 1.33 -however patient is already on Eliquis. No DVT noted on u/s. -- s/p decadron course -- s/p CAP treatment -- remains on eliquis as below     Atrial flutter with RVR, new Heart rate up to 160s on presentation, likely due to above. CHA2DS2-VASc score of 3. Over course of her admission, metoprolol added and dose increased. Diltiazem added. Continue as needed IV metoprolol. Cardiology consulted, appreciate recommendations. Started on Eliquis 5 mg twice daily. Normal TSH -- cont metoprolol, diltiazem, eliquis -- Continue telemetry monitor -- F/U up with cardiology as an outpatient   Hx of Hypertension continue lisinopril, metoprolol    Type 2 diabetes with hyperglycemia  Hx of type 2 diabetes mellitus on Metformin and glipizide PTA.  Lantus increased doses this admission and now up to 50 units twice daily while on steroids BG today a.m. was 107.  Lantus lowered from 40 BID to 40 units qhs,  She is off steroids, so requiring less insulin cont scheduled mealtime insulin as per carb count increased to 4 units per carb choice.  A1c 10.1 on January 3. Cont home oral DM regimen w/ glipizide, metformin. Cont to wean down insulin as able.    History of schizophrenia, schizoaffective disorder bipolar type, history of psychosis Resume home medications Received monthly paliperidone injection on 1/12.   Hx of OSA, obesity    VTE PPX: Eliquis Code- Full   Dispo:  No further inpatient work-up anticipated.  Awaiting group home to take the patient back
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer increased, Glycosylated haemoglobin increased, Hyperglycaemia, Pneumonia bacterial, Pyrexia
Clinical narrative: 52 y.o. female with history as outlined below as well as pertinent history of morbid obesity and type 2 diabetes mellitus who was referred to the ER from her clinic for evaluation of new onset atrial flutter.   Acute respiratory failure with hypoxia, resolved Pneumonia due to COVID-19, improved Likely bacterial pneumonia Fever, resolved Pt with positive test for SARS-CoV-2 6 days PTA; she is vaccinated (received 2 doses of Moderna; has not received booster). Chest x-ray with findings suggestive of superimposed bacterial pneumonia (possibly improving, as patient has been on Augmentin since 12/30). Completed course while inpt w/ cefdinir, azithromycin. Placed on decadron given O2 requirements. Weaned off O2 on 1/10, stopped decadron. D-dimer was elevated 1.33 -however patient is already on Eliquis. No DVT noted on u/s. -- s/p decadron course -- s/p CAP treatment -- remains on eliquis as below     Atrial flutter with RVR, new Heart rate up to 160s on presentation, likely due to above. CHA2DS2-VASc score of 3. Over course of her admission, metoprolol added and dose increased. Diltiazem added. Continue as needed IV metoprolol. Cardiology consulted, appreciate recommendations. Started on Eliquis 5 mg twice daily. Normal TSH -- cont metoprolol, diltiazem, eliquis -- Continue telemetry monitor -- F/U up with cardiology as an outpatient   Hx of Hypertension continue lisinopril, metoprolol    Type 2 diabetes with hyperglycemia  Hx of type 2 diabetes mellitus on Metformin and glipizide PTA.  Lantus increased doses this admission and now up to 50 units twice daily while on steroids BG today a.m. was 107.  Lantus lowered from 40 BID to 40 units qhs,  She is off steroids, so requiring less insulin cont scheduled mealtime insulin as per carb count increased to 4 units per carb choice.  A1c 10.1 on January 3. Cont home oral DM regimen w/ glipizide, metformin. Cont to wean down insulin as able.    History of schizophrenia, schizoaffective disorder bipolar type, history of psychosis Resume home medications Received monthly paliperidone injection on 1/12.   Hx of OSA, obesity    VTE PPX: Eliquis Code- Full   Dispo:  No further inpatient work-up anticipated.  Awaiting group home to take the patient back
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Ultrasound Doppler normal
Clinical narrative: 52 y.o. female with history as outlined below as well as pertinent history of morbid obesity and type 2 diabetes mellitus who was referred to the ER from her clinic for evaluation of new onset atrial flutter.   Acute respiratory failure with hypoxia, resolved Pneumonia due to COVID-19, improved Likely bacterial pneumonia Fever, resolved Pt with positive test for SARS-CoV-2 6 days PTA; she is vaccinated (received 2 doses of Moderna; has not received booster). Chest x-ray with findings suggestive of superimposed bacterial pneumonia (possibly improving, as patient has been on Augmentin since 12/30). Completed course while inpt w/ cefdinir, azithromycin. Placed on decadron given O2 requirements. Weaned off O2 on 1/10, stopped decadron. D-dimer was elevated 1.33 -however patient is already on Eliquis. No DVT noted on u/s. -- s/p decadron course -- s/p CAP treatment -- remains on eliquis as below     Atrial flutter with RVR, new Heart rate up to 160s on presentation, likely due to above. CHA2DS2-VASc score of 3. Over course of her admission, metoprolol added and dose increased. Diltiazem added. Continue as needed IV metoprolol. Cardiology consulted, appreciate recommendations. Started on Eliquis 5 mg twice daily. Normal TSH -- cont metoprolol, diltiazem, eliquis -- Continue telemetry monitor -- F/U up with cardiology as an outpatient   Hx of Hypertension continue lisinopril, metoprolol    Type 2 diabetes with hyperglycemia  Hx of type 2 diabetes mellitus on Metformin and glipizide PTA.  Lantus increased doses this admission and now up to 50 units twice daily while on steroids BG today a.m. was 107.  Lantus lowered from 40 BID to 40 units qhs,  She is off steroids, so requiring less insulin cont scheduled mealtime insulin as per carb count increased to 4 units per carb choice.  A1c 10.1 on January 3. Cont home oral DM regimen w/ glipizide, metformin. Cont to wean down insulin as able.    History of schizophrenia, schizoaffective disorder bipolar type, history of psychosis Resume home medications Received monthly paliperidone injection on 1/12.   Hx of OSA, obesity    VTE PPX: Eliquis Code- Full   Dispo:  No further inpatient work-up anticipated.  Awaiting group home to take the patient back
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, COVID-19, Chest pain, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: Received Pfizer vaccines on  4/28, 5/19/21 COVID-19 positive by PCR on  1/10/22 admitted to hospital 1/10-1/13/22 for chest pain, abd pain, hypoxia in setting of COVID 19 past history of hypoplastic left heart s/p Fontan procedure, atrial flutter s/p placement of dual-chamber epicardial pacemaker 2018
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Neck pain
Clinical narrative: 2/17 Two weeks after vaccine 2nd dose, my lymph nodes were swollen and was told to allow it run it's course. Later pain in neck increased and sought care for it. Was referred to massage therapist where after 3 sessions was referred to a specialist who after the first session with her on 04/24 was able to  decrease pain significantly and restore about 90% movement to my neck.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Ear congestion, Joint swelling
Clinical narrative: 2 days Left Ear congestion, 6 days Left Elbow large swelling, 2 days chills, then 2 days chills again a few days later
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: hospitalization
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: states develop sx 1/13/2022- tested positive for covid on 1/14/22 binax rapid antigen test has had 2 doses of Moderna- 2nd dose listed above, no booster dose
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Body temperature increased, Brain oedema, COVID-19, Chemotherapy
Clinical narrative: Patient with a history of left frontal WHO grade 3 anaplastic oligodendroglioma, status post resection and radiation in 2019, then redo surgery May 2021 for enlarging recurrent left frontal enhancing mass with cerebral edema.  Per wife, had increasing weakness at home and arranged Inpatient rehab stay. While there, was not progressing as expected and had imaging that showed recurrence of cerebral edema, same site of both prior recurrences. Sent here to our ED as both prior operations with physician. He is slow to respond and initially said he was in a different location, but reorients and pleasant otherwise. He also follows with another physician and is currently on timozolomide (chemo). Fidgeting with his glasses and needs redirected frequently. Has low grade temp but on room air and no cough. Says he had his third COVID shot about a month ago. No known exposures but has been at rehab facility. Has no symptoms otherwise, but tested COVID positive here.   PT CONTINUES TO BE INPATIENT AT THIS TIME.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Disorientation, Imaging procedure abnormal, Intracranial mass, SARS-CoV-2 test positive, Slow response to stimuli
Clinical narrative: Patient with a history of left frontal WHO grade 3 anaplastic oligodendroglioma, status post resection and radiation in 2019, then redo surgery May 2021 for enlarging recurrent left frontal enhancing mass with cerebral edema.  Per wife, had increasing weakness at home and arranged Inpatient rehab stay. While there, was not progressing as expected and had imaging that showed recurrence of cerebral edema, same site of both prior recurrences. Sent here to our ED as both prior operations with physician. He is slow to respond and initially said he was in a different location, but reorients and pleasant otherwise. He also follows with another physician and is currently on timozolomide (chemo). Fidgeting with his glasses and needs redirected frequently. Has low grade temp but on room air and no cough. Says he had his third COVID shot about a month ago. No known exposures but has been at rehab facility. Has no symptoms otherwise, but tested COVID positive here.   PT CONTINUES TO BE INPATIENT AT THIS TIME.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tumour excision
Clinical narrative: Patient with a history of left frontal WHO grade 3 anaplastic oligodendroglioma, status post resection and radiation in 2019, then redo surgery May 2021 for enlarging recurrent left frontal enhancing mass with cerebral edema.  Per wife, had increasing weakness at home and arranged Inpatient rehab stay. While there, was not progressing as expected and had imaging that showed recurrence of cerebral edema, same site of both prior recurrences. Sent here to our ED as both prior operations with physician. He is slow to respond and initially said he was in a different location, but reorients and pleasant otherwise. He also follows with another physician and is currently on timozolomide (chemo). Fidgeting with his glasses and needs redirected frequently. Has low grade temp but on room air and no cough. Says he had his third COVID shot about a month ago. No known exposures but has been at rehab facility. Has no symptoms otherwise, but tested COVID positive here.   PT CONTINUES TO BE INPATIENT AT THIS TIME.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph node under left arm  Advised to continue ibuprofen, acetaminophen, and ice/warm compress
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Computerised tomogram, Disturbance in attention, Dizziness, Electroencephalogram
Clinical narrative: Severe tremors, muscle twitches, occasional  blurred vision, sudden weakness, light headed, foggy clouded mind, difficulty concentrating, and migraines.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Migraine, Muscle twitching, Tremor, Vision blurred
Clinical narrative: Severe tremors, muscle twitches, occasional  blurred vision, sudden weakness, light headed, foggy clouded mind, difficulty concentrating, and migraines.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Gait disturbance, Subdural haematoma
Clinical narrative: 68-year-old male with past medical history of AFib previously on warfarin therapy, hypertension, hyperlipidemia, BPH, and history subdural hematoma (SDH) previously on Keppra, who presents to the ER wife his wife and uncle due to a 1 day history of difficulty walking and AMS.  Patient was previously found to have large  SDH w/ 6 mm R to L shift,  2 months ago.  Neurosurgery was consulted and patient  was taken to the OR for burr holes and evacuation of SDH due to brain compression.  Patient was discharged  to encompass and received Keppra for 1 month.  Patient's son was contacted today and states the patient has been home for 1 month, since Dec 2021, and has been working with home health care who come to the patient's house 2 times per week. Last week, the patient's home health nurse tested positive for COVID-19. On Tuesday, the patient developed bad cough and became immobile (restricted in movement), and was not able to get up or use his walker.  Patient Son and the patient's nurse became concerned about patient's recent decline in physical mobility, so the patient was brought to the ER by his wife and Uncle for further evaluation.  In the ER the patient tested positive COVID and CT scan of his head was shown to have a subdural hematoma that had increasing in size since his previous scan.  Patient is currently AOx1.  Complains of recent blurry vision, headache, and difficulty walking.  Patient states he has had a stroke in the past which left him with mild left-sided weakness.  Denies chest pain, SOB, fever chills, nausea, vomiting, numbness and tingling.  Of note:  Patient has stopped taking Coumadin 2 months ago, after the surgery.  Patient has received both COVID vaccine and booster.  Patient lives at home receives  help from Home Health care 2x's per week, as well as assistance from patient son, spouse and family.  Patient's son states that POA is shared between patient is son, daughter, and patient's wife. Baseline: Takes meds, walks with walker and gait belt, AOx3 with slight confusion, requires assistance with eating; diet: solids, heart healthy. PT CONTINUES TO BE INPATIENT AT THIS TIME.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: unknown
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Dysstasia, Muscular weakness
Clinical narrative: Patient reported the next morning she had muscle weakness in legs to the point couldn't get out of bed and had to use her arms to move herself around.  Stated it last for maybe 24 hours and she has returned to normal
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: During a review of records, it was found that there might have been a possible temperature excursion with how the vaccine was stored with our mobile vendor.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Dysmenorrhoea, Fatigue, Heavy menstrual bleeding, Magnetic resonance imaging normal
Clinical narrative: Severe, persistent migraine.  Menstrual cycle seriously changed - heavier, very painful.  Fatigue.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Menstrual disorder, Migraine
Clinical narrative: Severe, persistent migraine.  Menstrual cycle seriously changed - heavier, very painful.  Fatigue.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Headache, Magnetic resonance imaging normal, Sinus disorder, Swelling
Clinical narrative: My normal sinus issues seemed to be magnified.  I have a headache that seems to never go away even taking medication for it.  My head swells causing my glass to sink into the side of my head.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram pulmonary abnormal, Asthenia, Atelectasis, Blood alkaline phosphatase increased, Blood creatinine normal
Clinical narrative: 81 yo F who gets most of her health care at Local Center. She has a PMH of polymyositis, restrictive lung disease on chronic 2L NC O2, Obesity, Graves Dis treated w/  I-131 now hypothyroid, chronic AFib on coumadin, CHF, CAD, PVD,  HX DVT, and RA. She is on chronic prednisone 5mg daily. She p/w worsening cough and progressively more SHOB over the past week with productive clear sputum. She denies chills, sweats, fevers, chest pain, hemoptysis, syncope, N/V, hematochezia, melena, abdomen pain, dysuria, HA or confusion. She has chronic peripheral edema and what she describes as chronic vascular leg wounds treated with wraps and HHN wound care. She feels weak and fatigued ---has limited mobility at baseline (wheelchair use) and found that she needed assist of 2 persons last eve to get up. She has had up to 3 loose stools daily over the past 5 days. She started cefuroxime (from her PCP for bronchitis) last pm, otherwise has had no recent antibiotics. In the ED, she has T 99.3,  HR 80s NSR on EKG, BPs 140-150s/60-80s, RR 26; hypoxic to 83% on RA; ABGs on home 2L O2: 7.36/54/75/30. She is up to 95% sat on her home 2L NC O2. She has leukopenia (3.43) and thrombocytopenia (98).  K+ 3.2, BUN/creatine 13/0.8, alk. phos 150, PCT 0/18, lactate nl, 5G TNT flat @ 37 x2. PT/INR 56.2/4.8. COVID positive. CXR: "medial RUL airspace dis, left basilar atelectasis vs airspace dis"; CTA chest:  "No PE; patchy consolidation RUL with patchy ground-glass changes seen in left lingula. Infectious process suspected--COVID pneumonia could give this appearance."  She had deep penetration on June 2021 VFSS. Rocephin and azithromycin was  started in the ED, pharmacist reported that patient, family, and her PCP office do not know if indeed an allergy to azithromycin and rocephin as listed and what RXN was --She tolerated first doses and will monitor on continued. Hospital Medicine has been asked to admit the patient. PATIENT IS INPATIENT AT THIS TIME.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood lactic acid normal, Blood potassium decreased, Blood urea normal, Bronchitis, COVID-19
Clinical narrative: 81 yo F who gets most of her health care at Local Center. She has a PMH of polymyositis, restrictive lung disease on chronic 2L NC O2, Obesity, Graves Dis treated w/  I-131 now hypothyroid, chronic AFib on coumadin, CHF, CAD, PVD,  HX DVT, and RA. She is on chronic prednisone 5mg daily. She p/w worsening cough and progressively more SHOB over the past week with productive clear sputum. She denies chills, sweats, fevers, chest pain, hemoptysis, syncope, N/V, hematochezia, melena, abdomen pain, dysuria, HA or confusion. She has chronic peripheral edema and what she describes as chronic vascular leg wounds treated with wraps and HHN wound care. She feels weak and fatigued ---has limited mobility at baseline (wheelchair use) and found that she needed assist of 2 persons last eve to get up. She has had up to 3 loose stools daily over the past 5 days. She started cefuroxime (from her PCP for bronchitis) last pm, otherwise has had no recent antibiotics. In the ED, she has T 99.3,  HR 80s NSR on EKG, BPs 140-150s/60-80s, RR 26; hypoxic to 83% on RA; ABGs on home 2L O2: 7.36/54/75/30. She is up to 95% sat on her home 2L NC O2. She has leukopenia (3.43) and thrombocytopenia (98).  K+ 3.2, BUN/creatine 13/0.8, alk. phos 150, PCT 0/18, lactate nl, 5G TNT flat @ 37 x2. PT/INR 56.2/4.8. COVID positive. CXR: "medial RUL airspace dis, left basilar atelectasis vs airspace dis"; CTA chest:  "No PE; patchy consolidation RUL with patchy ground-glass changes seen in left lingula. Infectious process suspected--COVID pneumonia could give this appearance."  She had deep penetration on June 2021 VFSS. Rocephin and azithromycin was  started in the ED, pharmacist reported that patient, family, and her PCP office do not know if indeed an allergy to azithromycin and rocephin as listed and what RXN was --She tolerated first doses and will monitor on continued. Hospital Medicine has been asked to admit the patient. PATIENT IS INPATIENT AT THIS TIME.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray abnormal, Cough, Diarrhoea, Dyspnoea, Fatigue
Clinical narrative: 81 yo F who gets most of her health care at Local Center. She has a PMH of polymyositis, restrictive lung disease on chronic 2L NC O2, Obesity, Graves Dis treated w/  I-131 now hypothyroid, chronic AFib on coumadin, CHF, CAD, PVD,  HX DVT, and RA. She is on chronic prednisone 5mg daily. She p/w worsening cough and progressively more SHOB over the past week with productive clear sputum. She denies chills, sweats, fevers, chest pain, hemoptysis, syncope, N/V, hematochezia, melena, abdomen pain, dysuria, HA or confusion. She has chronic peripheral edema and what she describes as chronic vascular leg wounds treated with wraps and HHN wound care. She feels weak and fatigued ---has limited mobility at baseline (wheelchair use) and found that she needed assist of 2 persons last eve to get up. She has had up to 3 loose stools daily over the past 5 days. She started cefuroxime (from her PCP for bronchitis) last pm, otherwise has had no recent antibiotics. In the ED, she has T 99.3,  HR 80s NSR on EKG, BPs 140-150s/60-80s, RR 26; hypoxic to 83% on RA; ABGs on home 2L O2: 7.36/54/75/30. She is up to 95% sat on her home 2L NC O2. She has leukopenia (3.43) and thrombocytopenia (98).  K+ 3.2, BUN/creatine 13/0.8, alk. phos 150, PCT 0/18, lactate nl, 5G TNT flat @ 37 x2. PT/INR 56.2/4.8. COVID positive. CXR: "medial RUL airspace dis, left basilar atelectasis vs airspace dis"; CTA chest:  "No PE; patchy consolidation RUL with patchy ground-glass changes seen in left lingula. Infectious process suspected--COVID pneumonia could give this appearance."  She had deep penetration on June 2021 VFSS. Rocephin and azithromycin was  started in the ED, pharmacist reported that patient, family, and her PCP office do not know if indeed an allergy to azithromycin and rocephin as listed and what RXN was --She tolerated first doses and will monitor on continued. Hospital Medicine has been asked to admit the patient. PATIENT IS INPATIENT AT THIS TIME.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoxia, International normalised ratio increased, Leukopenia, Lung disorder, Lung opacity
Clinical narrative: 81 yo F who gets most of her health care at Local Center. She has a PMH of polymyositis, restrictive lung disease on chronic 2L NC O2, Obesity, Graves Dis treated w/  I-131 now hypothyroid, chronic AFib on coumadin, CHF, CAD, PVD,  HX DVT, and RA. She is on chronic prednisone 5mg daily. She p/w worsening cough and progressively more SHOB over the past week with productive clear sputum. She denies chills, sweats, fevers, chest pain, hemoptysis, syncope, N/V, hematochezia, melena, abdomen pain, dysuria, HA or confusion. She has chronic peripheral edema and what she describes as chronic vascular leg wounds treated with wraps and HHN wound care. She feels weak and fatigued ---has limited mobility at baseline (wheelchair use) and found that she needed assist of 2 persons last eve to get up. She has had up to 3 loose stools daily over the past 5 days. She started cefuroxime (from her PCP for bronchitis) last pm, otherwise has had no recent antibiotics. In the ED, she has T 99.3,  HR 80s NSR on EKG, BPs 140-150s/60-80s, RR 26; hypoxic to 83% on RA; ABGs on home 2L O2: 7.36/54/75/30. She is up to 95% sat on her home 2L NC O2. She has leukopenia (3.43) and thrombocytopenia (98).  K+ 3.2, BUN/creatine 13/0.8, alk. phos 150, PCT 0/18, lactate nl, 5G TNT flat @ 37 x2. PT/INR 56.2/4.8. COVID positive. CXR: "medial RUL airspace dis, left basilar atelectasis vs airspace dis"; CTA chest:  "No PE; patchy consolidation RUL with patchy ground-glass changes seen in left lingula. Infectious process suspected--COVID pneumonia could give this appearance."  She had deep penetration on June 2021 VFSS. Rocephin and azithromycin was  started in the ED, pharmacist reported that patient, family, and her PCP office do not know if indeed an allergy to azithromycin and rocephin as listed and what RXN was --She tolerated first doses and will monitor on continued. Hospital Medicine has been asked to admit the patient. PATIENT IS INPATIENT AT THIS TIME.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mobility decreased, Oedema peripheral, Peripheral vascular disorder, Platelet count decreased, Procalcitonin
Clinical narrative: 81 yo F who gets most of her health care at Local Center. She has a PMH of polymyositis, restrictive lung disease on chronic 2L NC O2, Obesity, Graves Dis treated w/  I-131 now hypothyroid, chronic AFib on coumadin, CHF, CAD, PVD,  HX DVT, and RA. She is on chronic prednisone 5mg daily. She p/w worsening cough and progressively more SHOB over the past week with productive clear sputum. She denies chills, sweats, fevers, chest pain, hemoptysis, syncope, N/V, hematochezia, melena, abdomen pain, dysuria, HA or confusion. She has chronic peripheral edema and what she describes as chronic vascular leg wounds treated with wraps and HHN wound care. She feels weak and fatigued ---has limited mobility at baseline (wheelchair use) and found that she needed assist of 2 persons last eve to get up. She has had up to 3 loose stools daily over the past 5 days. She started cefuroxime (from her PCP for bronchitis) last pm, otherwise has had no recent antibiotics. In the ED, she has T 99.3,  HR 80s NSR on EKG, BPs 140-150s/60-80s, RR 26; hypoxic to 83% on RA; ABGs on home 2L O2: 7.36/54/75/30. She is up to 95% sat on her home 2L NC O2. She has leukopenia (3.43) and thrombocytopenia (98).  K+ 3.2, BUN/creatine 13/0.8, alk. phos 150, PCT 0/18, lactate nl, 5G TNT flat @ 37 x2. PT/INR 56.2/4.8. COVID positive. CXR: "medial RUL airspace dis, left basilar atelectasis vs airspace dis"; CTA chest:  "No PE; patchy consolidation RUL with patchy ground-glass changes seen in left lingula. Infectious process suspected--COVID pneumonia could give this appearance."  She had deep penetration on June 2021 VFSS. Rocephin and azithromycin was  started in the ED, pharmacist reported that patient, family, and her PCP office do not know if indeed an allergy to azithromycin and rocephin as listed and what RXN was --She tolerated first doses and will monitor on continued. Hospital Medicine has been asked to admit the patient. PATIENT IS INPATIENT AT THIS TIME.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Productive cough, Prothrombin time prolonged, SARS-CoV-2 test positive, Thrombocytopenia, Wheelchair user
Clinical narrative: 81 yo F who gets most of her health care at Local Center. She has a PMH of polymyositis, restrictive lung disease on chronic 2L NC O2, Obesity, Graves Dis treated w/  I-131 now hypothyroid, chronic AFib on coumadin, CHF, CAD, PVD,  HX DVT, and RA. She is on chronic prednisone 5mg daily. She p/w worsening cough and progressively more SHOB over the past week with productive clear sputum. She denies chills, sweats, fevers, chest pain, hemoptysis, syncope, N/V, hematochezia, melena, abdomen pain, dysuria, HA or confusion. She has chronic peripheral edema and what she describes as chronic vascular leg wounds treated with wraps and HHN wound care. She feels weak and fatigued ---has limited mobility at baseline (wheelchair use) and found that she needed assist of 2 persons last eve to get up. She has had up to 3 loose stools daily over the past 5 days. She started cefuroxime (from her PCP for bronchitis) last pm, otherwise has had no recent antibiotics. In the ED, she has T 99.3,  HR 80s NSR on EKG, BPs 140-150s/60-80s, RR 26; hypoxic to 83% on RA; ABGs on home 2L O2: 7.36/54/75/30. She is up to 95% sat on her home 2L NC O2. She has leukopenia (3.43) and thrombocytopenia (98).  K+ 3.2, BUN/creatine 13/0.8, alk. phos 150, PCT 0/18, lactate nl, 5G TNT flat @ 37 x2. PT/INR 56.2/4.8. COVID positive. CXR: "medial RUL airspace dis, left basilar atelectasis vs airspace dis"; CTA chest:  "No PE; patchy consolidation RUL with patchy ground-glass changes seen in left lingula. Infectious process suspected--COVID pneumonia could give this appearance."  She had deep penetration on June 2021 VFSS. Rocephin and azithromycin was  started in the ED, pharmacist reported that patient, family, and her PCP office do not know if indeed an allergy to azithromycin and rocephin as listed and what RXN was --She tolerated first doses and will monitor on continued. Hospital Medicine has been asked to admit the patient. PATIENT IS INPATIENT AT THIS TIME.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: White blood cell count decreased
Clinical narrative: 81 yo F who gets most of her health care at Local Center. She has a PMH of polymyositis, restrictive lung disease on chronic 2L NC O2, Obesity, Graves Dis treated w/  I-131 now hypothyroid, chronic AFib on coumadin, CHF, CAD, PVD,  HX DVT, and RA. She is on chronic prednisone 5mg daily. She p/w worsening cough and progressively more SHOB over the past week with productive clear sputum. She denies chills, sweats, fevers, chest pain, hemoptysis, syncope, N/V, hematochezia, melena, abdomen pain, dysuria, HA or confusion. She has chronic peripheral edema and what she describes as chronic vascular leg wounds treated with wraps and HHN wound care. She feels weak and fatigued ---has limited mobility at baseline (wheelchair use) and found that she needed assist of 2 persons last eve to get up. She has had up to 3 loose stools daily over the past 5 days. She started cefuroxime (from her PCP for bronchitis) last pm, otherwise has had no recent antibiotics. In the ED, she has T 99.3,  HR 80s NSR on EKG, BPs 140-150s/60-80s, RR 26; hypoxic to 83% on RA; ABGs on home 2L O2: 7.36/54/75/30. She is up to 95% sat on her home 2L NC O2. She has leukopenia (3.43) and thrombocytopenia (98).  K+ 3.2, BUN/creatine 13/0.8, alk. phos 150, PCT 0/18, lactate nl, 5G TNT flat @ 37 x2. PT/INR 56.2/4.8. COVID positive. CXR: "medial RUL airspace dis, left basilar atelectasis vs airspace dis"; CTA chest:  "No PE; patchy consolidation RUL with patchy ground-glass changes seen in left lingula. Infectious process suspected--COVID pneumonia could give this appearance."  She had deep penetration on June 2021 VFSS. Rocephin and azithromycin was  started in the ED, pharmacist reported that patient, family, and her PCP office do not know if indeed an allergy to azithromycin and rocephin as listed and what RXN was --She tolerated first doses and will monitor on continued. Hospital Medicine has been asked to admit the patient. PATIENT IS INPATIENT AT THIS TIME.
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: No adverse events.   Did have COVID 1/12/2022
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, COVID-19 pneumonia, Dyspnoea, Interchange of vaccine products
Clinical narrative: Received Janssen vaccine on 3/10/21; Moderna vaccine on 11/11/21 COVID-19 positive by PCR on  12/10/21, 1/10/22 admitted to hospital on 1/10/22 d/t SOB, ongoing weakness, dyspnea, myalgia following COVID diagnosis in Dec 2021. Diagnosed w/ COVID pneumonia, patchy bronchopneumonia underlying history of cystic fibrosis w/ h/o lung transplant 2015, Type 1 DM, Stage III CKD
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Pneumonia, SARS-CoV-2 test positive
Clinical narrative: Received Janssen vaccine on 3/10/21; Moderna vaccine on 11/11/21 COVID-19 positive by PCR on  12/10/21, 1/10/22 admitted to hospital on 1/10/22 d/t SOB, ongoing weakness, dyspnea, myalgia following COVID diagnosis in Dec 2021. Diagnosed w/ COVID pneumonia, patchy bronchopneumonia underlying history of cystic fibrosis w/ h/o lung transplant 2015, Type 1 DM, Stage III CKD
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain lower, Atrial fibrillation, COVID-19, Computerised tomogram abdomen normal, Computerised tomogram abnormal
Clinical narrative: A 73-year-old female, long-term care resident at Health and Rehab under the care of Dr., was sent to the emergency room tonight by staff at the nursing home.  The patient has some baseline dementia and acutely confused on top of that, so history is sketchy from her.  She complains of some suprapubic and left lower quadrant abdominal pain.  I was initially called to admit the patient for what was felt to be a possible appendicitis, new onset atrial fibrillation, electrolyte disturbances.  I called and spoke with the nurse who cares for her at the nursing home.  The patient the previous night had prolonged vomiting for 4-5 hours,  then subsided during the day today.  A KUB was done at the nursin nursing home yesterday  morning, which the nurse said was read as unremarkable.  However, this evening vomiting  began again.  The patient then became slightly confused from her baseline, had elevated temperature 99.4, blood pressure 176/88, so they sent her to the emergency room.  On arrival to the ED, she was in atrial fibrillation with a rate in the 120-range and was given IV diltiazem.  Because of elevated white blood cell count and  possible appendicitis on CT, Invanz was ordered in the ED.  A CT angiogram of the abdomen  and pelvis was done that was fairly unremarkable, although VRad noted they could not  completely rule out appendicitis.  Of note, the patient was diagnosed with COVID on January 5th and started on dexamethasone 6 mg daily on January 6th, which she is still taking.  No chest x-ray has been done yet.  Her oxygen saturation is 98% on room air.   PT IS STILL AN INPATIENT IN THIS TIME.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Confusional state, Dementia, Electrolyte imbalance, Suprapubic pain
Clinical narrative: A 73-year-old female, long-term care resident at Health and Rehab under the care of Dr., was sent to the emergency room tonight by staff at the nursing home.  The patient has some baseline dementia and acutely confused on top of that, so history is sketchy from her.  She complains of some suprapubic and left lower quadrant abdominal pain.  I was initially called to admit the patient for what was felt to be a possible appendicitis, new onset atrial fibrillation, electrolyte disturbances.  I called and spoke with the nurse who cares for her at the nursing home.  The patient the previous night had prolonged vomiting for 4-5 hours,  then subsided during the day today.  A KUB was done at the nursin nursing home yesterday  morning, which the nurse said was read as unremarkable.  However, this evening vomiting  began again.  The patient then became slightly confused from her baseline, had elevated temperature 99.4, blood pressure 176/88, so they sent her to the emergency room.  On arrival to the ED, she was in atrial fibrillation with a rate in the 120-range and was given IV diltiazem.  Because of elevated white blood cell count and  possible appendicitis on CT, Invanz was ordered in the ED.  A CT angiogram of the abdomen  and pelvis was done that was fairly unremarkable, although VRad noted they could not  completely rule out appendicitis.  Of note, the patient was diagnosed with COVID on January 5th and started on dexamethasone 6 mg daily on January 6th, which she is still taking.  No chest x-ray has been done yet.  Her oxygen saturation is 98% on room air.   PT IS STILL AN INPATIENT IN THIS TIME.